BREAKING: CDC AWARDS PFIZER $1.24 BILLION FOR INFANT & ADULT COVID-19 mRNA INJECTIONS
The CDC announced two new contracts with Pfizer on June 1, totaling $1.24 billion for COVID‑19 mRNA vaccines covering fiscal years 2026 and 2027. The awards split into $735.7 million for pediatric doses and $505.3 million for adult doses. Despite a sharp decline in vaccine demand, the agency is committing hundreds of millions to future purchases. The contracts come amid heightened scrutiny of the vaccines’ safety record and public‑health spending.
Peter Hotez Named In Sexual Harassment/Wrongful Termination Lawsuit
Dr. Annette Lee, a senior Northwell Health scientist, filed a federal wrongful‑termination lawsuit alleging retaliation after she rebuffed advances from vaccine researcher Peter Hotez. The complaint, filed in the Eastern District of New York in May 2026, details a May...
NEW STUDY: Advanced Alzheimer’s Patient Regained Speech, Memory, and Bladder Control After a Single Psilocybin Dose
A newly published case report in Frontiers in Neuroscience describes an 80‑year‑old woman with advanced Alzheimer’s who experienced rapid, multi‑domain functional recovery after a single 5 gram oral dose of psilocybin‑containing mushrooms. Within 19 hours she regained speech, autobiographical memory, mobility, emotional...
How 18 Million Tweets Proved COVID-19 Vaccination Was a Successful Fear Management Campaign
Researchers analyzed 18 million geotagged tweets from over 3,000 U.S. counties spanning the 100 days before and after the first COVID‑19 vaccine was administered on December 14, 2020. Using the NRC Word‑Emotion Association Lexicon, they tracked changes in fear, anger, joy and sadness. The...
The Booster Industrial Complex Marches On
On May 28, 2026, the FDA’s Vaccines and Related Biological Products Advisory Committee voted 8‑0‑1 to recommend that the upcoming fall 2026 COVID‑19 booster target the XFG (nicknamed “stratus”) variant, now responsible for over half of U.S. infections. The recommendation...
The Fascinating Properties of Ivermectin
The post spotlights new research on ivermectin’s anti‑cancer potential while revisiting its historic discovery and essential‑medicine status. It recounts the 2020 Monash in‑vitro study that showed a 5,000‑fold reduction of SARS‑CoV‑2, the 2020 Florida cohort linking the drug to lower...
Study Reports 96% Remission Rate of Alpha-Gal Syndrome with Auricular Acupuncture
A peer‑reviewed case series of 137 alpha‑gal syndrome patients treated with Soliman Auricular Allergy Treatment (SAAT) reported a 96% remission rate. The protocol involved ear‑point acupuncture while patients touched an allergen vial, followed by a three‑week needle dwell. Over 93%...
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a Major Cancer Journal
A prospective real‑world cohort of 197 cancer patients treated with a compounded ivermectin‑mebendazole capsule (25 mg ivermectin, 250 mg mebendazole) has been peer‑reviewed and published in Anticancer Research. After roughly six months, 84.4% of participants reported a clinical benefit—remission, tumor regression, or...
BREAKING: Study Finds Pediatric Flu Shots Are a COMPLETE FAILURE
A peer‑reviewed study of a Spanish health region covering about 400,000 residents found that expanding flu vaccination to children aged six months to five years did not produce a statistically significant decline in influenza diagnoses or related hospitalizations. Researchers analyzed...
The Bedrock of Containment: Why Sanitation Is the Key to Controlling Ebola
The blog post by Dr. Peter A. McCullough argues that effective sanitation and strict barrier control are the cornerstone of Ebola containment, citing the Czerniewska and White (2020) case study of Liberia’s 2014‑2016 outbreak. It stresses that Ebola spreads through...
Peer-Reviewed Paper Says Genetically Engineering Ticks to Spread Meat Allergies Is “Morally Obligatory"
A peer‑reviewed paper argues that genetically editing lone‑star ticks to spread alpha‑gal syndrome—a meat allergy—constitutes a moral bio‑enhancement. The authors claim the ticks could be engineered to carry the allergy, survive longer, and avoid other diseases, making meat consumption less...
Moderna Began Developing a Bundibugyo Ebola mRNA “Vaccine” Just 4 Months Before WHO Declared a Global Emergency
In January 2026, CEPI granted $26.7 million to Moderna and the University of Oxford to start mRNA and viral‑vector vaccine work against the Bundibugyo ebolavirus as part of a multivalent filovirus platform. Four months later, the WHO declared a Public Health...
PROVIDENT: NIAID's Andes Virus Research Project Launched in 2024
Project PROVIDENT, a $70 million NIAID‑funded initiative launched in September 2024, aims to build plug‑and‑play vaccine and monoclonal‑antibody platforms for high‑risk RNA viruses. Led by Dr. Kartik Chandran at Albert Einstein College of Medicine, the effort unites 13 academic, government and industry...
BREAKING: Landmark Peer-Reviewed Study Finds Vaccination Is a Major Risk Factor for Autism
{"summary":"The post claims a new peer‑reviewed study links routine childhood vaccination to a higher risk of autism, citing that 107 of 136 vaccine‑related studies allegedly support this connection. It frames autism as a multifactorial disorder but argues that vaccines are...
How Did Germany Become a Moronic Inferno?
The author reflects on a recent AUF1 anniversary party in Austria, using the far‑right channel’s clash with German authorities to argue that free speech should protect dissenting voices, not just mainstream consensus. AUF1, monitored by the German Federal Office for...